Cell therapy wins FDA recommendation

Chan
Posted: 07/14/2017

The US FDA’s recommended approval of Novartis’ CAR-T cell therapy pushes the product closer to being the first treatment of its kind available on the market.Bruno Strigini, CEO, Novartis Oncology said: "The panel's unanimous recommendation in favor of CTL019 moves us closer to potentially delivering the first-ever commercially approved CAR-T

To continue viewing this content please fill out the form below and become an Pharma IQ member.
Or if you're already a Pharma IQ member, sign in below to download.
Subscribe

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product and you agree to our User Agreement, Privacy Policy, and Cookie Policy.

Chan
Posted: 07/14/2017

Pharma IQ Members

EVENTS OF INTEREST

Sheraton Munich Arabellapark Hotel, Munich, Germany
October 23 - 24, 2017
Hilton London Kensington, London, United Kingdom
October 23 - 25, 2017
The Highland, Dallas, TX, United States
October 24 - 26, 2017